Literature DB >> 19454431

Nasopharyngeal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

A T C Chan1, E Felip.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19454431     DOI： 10.1093/annonc/mdp150

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  19 in total

1.  Human nasopharyngeal carcinoma can be radiosensitized by trichosanthin via inhibition of the PI3K pathway.

Authors:  Wen Wang; Bo Tan; Jingwei Zhang; Rongliang Qiu; Xinju Liu; Dongmei Liu; Xue Li; Jianhua Wang
Journal:  Exp Ther Med       Date:  2018-09-11       Impact factor: 2.447

2.  Value of contrast-enhanced MRI in the differentiation between nasopharyngeal lymphoid hyperplasia and T1 stage nasopharyngeal carcinoma.

Authors:  Ming-Liang Wang; Xiao-Er Wei; Meng-Meng Yu; Wen-Bin Li
Journal:  Radiol Med       Date:  2017-06-24       Impact factor: 3.469

3.  Anti-epidermal growth factor receptor therapy for advanced head and neck squamous cell carcinoma: a meta-analysis.

Authors:  Shoude Zhang; Jia Chen; Hua Jiang; Haina Ma; Beibei Yang
Journal:  Eur J Clin Pharmacol       Date:  2012-01-10       Impact factor: 2.953

4.  Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells.

Authors:  Claire Gourzones; Aurore Gelin; Izabela Bombik; Jihène Klibi; Benjamin Vérillaud; Joël Guigay; Philippe Lang; Stéphane Témam; Véronique Schneider; Corinne Amiel; Sonia Baconnais; Anne-Sophie Jimenez; Pierre Busson
Journal:  Virol J       Date:  2010-10-15       Impact factor: 4.099

5.  Role of EGFR as a prognostic factor for survival in head and neck cancer: a meta-analysis.

Authors:  Shen Keren; Zhang Shoude; Zhao Lu; Yang Beibei
Journal:  Tumour Biol       Date:  2014-03

6.  Nasopharyngeal carcinoma in Slovenia, 1990-2003 (results of treatment with conventional two-dimensional radiotherapy).

Authors:  Janka Carman; Primož Strojan
Journal:  Rep Pract Oncol Radiother       Date:  2012-03-06

7.  Expression of RRM1 and its association with resistancy to gemcitabine-based chemotherapy in advanced nasopharyngeal carcinoma.

Authors:  Li-Ping Zhao; Cong Xue; Jian-Wei Zhang; Zhi-Huang Hu; Yuan-Yuan Zhao; Jing Zhang; Yan Huang; Hong-Yun Zhao; Li Zhang
Journal:  Chin J Cancer       Date:  2012-06-06

8.  BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro.

Authors:  Ziwei Tu; Bingqing Xu; Chen Qu; Yalan Tao; Chen Chen; Wenfeng Hua; Guokai Feng; Hui Chang; Zhigang Liu; Guo Li; Changbin Jiang; Wei Yi; Musheng Zeng; Yunfei Xia
Journal:  Radiat Oncol       Date:  2015-05-30       Impact factor: 3.481

9.  Consistent high concentration of the viral microRNA BART17 in plasma samples from nasopharyngeal carcinoma patients--evidence of non-exosomal transport.

Authors:  Claire Gourzones; François-Régis Ferrand; Corinne Amiel; Benjamin Vérillaud; Ana Barat; Maryse Guérin; Charles-Henry Gattolliat; Aurore Gelin; Jihène Klibi; Arij Ben Chaaben; Véronique Schneider; Fethi Guemira; Joël Guigay; Philippe Lang; Anne-Sophie Jimenez-Pailhes; Pierre Busson
Journal:  Virol J       Date:  2013-04-16       Impact factor: 4.099

10.  Arterial interventional chemotherapy and IMRT with concurrent chemotherapy for nasopharyngeal carcinoma with intracranial involvement.

Authors:  Xinglai Fen; Weifeng Qin; Wuan Bao; Feng Jiang; Bin Li; Fujun Hu; Xiaozhong Chen
Journal:  Oncol Lett       Date:  2013-06-17       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.